SCHEMBL14764482

SCHEMBL14764482

Cc1nc2ccncc2[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.47
PKM P14618 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
AURKA O14965 1/20 0.45
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 3/20 0.45
HPGD P15428 2/20 0.45
JMJD6 Q6NYC1 1/20 0.45
PARP1 P09874 1/20 0.45
METAP1 P53582 2/20 0.44
METAP2 P50579 1/20 0.44
PDE5A O76074 2/20 0.43
HPSE Q9Y251 1/20 0.42
KDM5A P29375 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
FGFR1 P11362 2/20 0.42
FLT1 P17948 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9110160 0.86 DAO (0.47) DAOPARP1KDM5AFGFR1FLT1
SCHEMBL879284 0.77 ALDH1A1 (0.50) PKMSMN1; SMN2NPC1RAB9AAURKA
SCHEMBL1589916 0.76 PLAUR (0.61) PKMSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30617972 0.76 PLAUR (0.61) PKMSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL14764938 0.73 PIN1 (0.56) DAONPC1RAB9AAURKAALDH1A1
SCHEMBL1170780 0.72 ALDH1A1 (0.68) PKMSMN1; SMN2NPC1RAB9AAURKA
SCHEMBL15906825 0.71 DAO (0.65) DAOPARP1KDM5A
SCHEMBL24112428 0.70 KDM4E (0.49) PKMSMN1; SMN2NPC1RAB9AAURKA
SCHEMBL2178282 0.70 KDM4E (0.52) DAOKDM4EPARP1METAP1METAP2
SCHEMBL14474322 0.70 ALDH1A1 (0.54) RAB9AAURKAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9056863-B2 Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof H. LUNDBECK A/S (DK) 2015-06-16 US disclosed
US-20140235645-A1 Pyridine Compounds and Uses Thereof H. LUNDBECK A/S (DK) 2014-08-21 US disclosed
EP-2763989-A1 PYRIDINE COMPOUNDS AND USES THEREOF H. Lundbeck A/S (DK) 2014-08-13 EP disclosed
WO-2013034761-A1 PYRIDINE COMPOUNDS AND USES THEREOF H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235645-A1 Pyridine Compounds and Uses Thereof ATP6V1B2, NDUFS5, MT-ND5 DAO 714/4885PKM 253/4885SMN1; SMN2 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.